EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Furin as a Novel Pan-Viral Therapeutic Target: Implications for Dengue and SARS-CoV-2

Lina Shalaby iD, Yaman Al-Haneedi, Alaa Abdelhamid, Hadi Yassine iD, Mohamed M Emara

Viruses · 29.04.2026 · 18 (5) · 509

DOI: 10.3390/v18050509 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 29.04.2026. Verfasst von Lina Shalaby und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Wayne State University, Detroit, MI 48201, USA. Hauptthemen laut MEDLINE: Furin, Antiviral Agents, Dengue Virus, SARS-CoV-2. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar Research, Development and Innovation Council, Academic Research, Qatar Research, Development and Innovation Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue virus (DENV) and SARS-CoV-2 are emerging viral pathogens that share overlapping clinical features, including fever, fatigue, and respiratory symptoms, complicating differential diagnosis in endemic regions. Their co-circulation has increased the risk of co-infections, which may result in unpredictable disease progression, increased morbidity, and mortality. This overlap presents a significant challenge in managing outbreaks, as both viruses pose a major public health threat. Vaccines and direct-acting antivirals may be rendered ineffective by viral mutations, making it difficult to address evolving strains. Host-directed antivirals offer a promising alternative, potentially maintaining efficacy against a multitude of variants. Both DENV and SARS-CoV-2 rely on host proteases for viral maturation and entry, with furin playing a crucial role in viral glycoprotein cleavage. In DENV, furin cleaves the prM protein, facilitating virion maturation, while in SARS-CoV-2, the polybasic furin cleavage site in the spike protein enhances viral entry. This makes furin a compelling pan-viral target, where inhibiting furin could reduce viral fitness without relying on viral mutations. This review highlights the therapeutic rationale for targeting furin and discusses luteolin, a furin inhibitor showing antiviral activity against both viruses. Furin-targeted therapies may offer a durable antiviral strategy effective across DENV serotypes, SARS-CoV-2 variants, and co-infection settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FurinAntiviral AgentsDengue VirusSARS-CoV-2DengueCOVID-19 Drug TreatmentHumansVirus InternalizationCOVID-19AnimalsHost-Directed TherapySpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

SARS-CoV-2co-infectiondengue virusdirect-acting antiviralsfurinhost-directed antiviralsprotease inhibitorsvaccines

Substanzen

FurinAntiviral AgentsSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • School of Medicine, Wayne State University, Detroit, MI 48201, USA.
  • Basic Medical Sciences Department, College of Medicine, Qatar University Health, Qatar University, Doha P.O. Box 2713, Qatar.
  • Biomedical Research Center, Qatar University Health, Qatar University, Doha P.O. Box 2713, Qatar.
  • College of Health Sciences, Qatar University, Doha P.O. Box 2713, Qatar.

ORCID-Profile: Lina Shalaby, Hadi Yassine

Förderung

  • Qatar Research, Development and Innovation Council, Academic Research
  • Qatar Research, Development and Innovation Council

Zitieren

APA

Shalaby, L., Al-Haneedi, Y., Abdelhamid, A., Yassine, H., & Emara, M. M. (2026). Furin as a Novel Pan-Viral Therapeutic Target: Implications for Dengue and SARS-CoV-2. Viruses, 18(5), 509. https://doi.org/10.3390/v18050509

Vancouver

Shalaby L, Al-Haneedi Y, Abdelhamid A, Yassine H, Emara MM. Furin as a Novel Pan-Viral Therapeutic Target: Implications for Dengue and SARS-CoV-2. Viruses. 2026;18(5):509. doi:10.3390/v18050509

BibTeX
@article{Shalaby2026,
  author = {Shalaby, Lina and Al-Haneedi, Yaman and Abdelhamid, Alaa and Yassine, Hadi and Emara, Mohamed M},
  title = {Furin as a Novel Pan-Viral Therapeutic Target: Implications for Dengue and SARS-CoV-2},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {509},
  doi = {10.3390/v18050509}
}
Kostenlos starten →